Storage and Handling of Ophthalmic Products: A Complete Guide for Pharmacies and Patients

A perfectly manufactured eye drop can be ruined between the factory gate and the patient's eye. Heat in a distributor's godown, sunlight on a pharmacy shelf, a contaminated dropper tip in a hospital ward, a bottle kept long past its in-use date — each silently degrades the product or turns it into an infection risk. Because ophthalmic products are sterile preparations for an organ with almost no tolerance for contamination, storage and handling discipline is not housekeeping; it is the final link of the quality chain.

This guide covers the full journey: warehouse and distribution, the hospital pharmacy, the clinic and operating theatre, and finally the patient's home — with the evidence and the label as the reference points.

Reading the Label: What Storage Instructions Actually Mean

Storage conditions on an ophthalmic carton are not suggestions — they are the output of ICH-aligned stability studies (long-term, accelerated and photostability) conducted on that specific product in that specific pack:

• "Store below 25°C / 30°C" — the validated maximum for the labelled shelf life. Much of India's ambient climate exceeds 30°C for months at a stretch, making air-conditioned storage a necessity, not a luxury, for many products.
• "Protect from light" — photostability data (ICH Q1B) showed light-driven degradation; the carton and any amber or opaque packaging are part of the protection system. Keep bottles in cartons until use.
• "Store in a refrigerator (2–8°C)" — required for specific formulations (e.g., certain prostaglandin analogues unopened, some compounded or biologic products). This triggers genuine cold-chain obligations.
• "Do not freeze" — freezing can break emulsions, precipitate actives and crack container seals. A refrigerated product accidentally frozen should be discarded.

The golden rule: the labelled expiry date is valid only if labelled storage conditions were met throughout.

Warehouse and Distribution: Where Most Failures Are Invisible

For distributors and stockists, ophthalmic storage failures rarely announce themselves — the bottle looks fine while assay drifts or a seal weakens. Good practice:

• Mapped, monitored storage. Temperature-mapping of the storage area, calibrated monitoring devices, and documented excursions with disposition decisions. India's summer godowns routinely exceed 40°C without air-conditioning.
• FEFO discipline. First-Expiry-First-Out picking, not just FIFO. Near-expiry stock flagged at defined thresholds (e.g., 6 months) and rotated to faster-moving counters or returned per the supplier's expiry policy.
• Carton integrity. Keep master cartons sealed until order picking; light, dust and monsoon humidity all attack secondary packaging and labels.
• Cold chain where labelled. Refrigerated lines need validated cold rooms, temperature-logged transport, and defined handling at every hand-off. A broken cold chain voids the stability justification for shelf life. Calibrated data loggers — not wall thermometers checked once a day — are the defensible standard, and every excursion needs a documented disposition decision with the manufacturer's stability data as the reference.
• Quarantine and recall readiness. Segregated quarantine for returns, damaged stock and recalled batches, with batch-level traceability — a revised Schedule M expectation on the manufacturing side that good distributors mirror.

Hospital Pharmacy and Ward: High Stakes, High Traffic

Hospital environments add their own risks: many hands, many patients, and bottles that travel. Published reviews of in-use eye drops repeatedly find contamination of dropper tips and caps, with rates climbing where bottles are shared between patients.

• Dedicated storage. Eye drops in a designated, clean, temperature-controlled area — never on window sills, never loose in procedure trolleys for days.
• Single-patient assignment. Best practice — and the policy in many accredited hospitals — is one bottle, one patient, labelled with patient name and date of first opening. Where multidose bottles must serve multiple patients (a policy choice some surgical facilities make), strict aseptic technique and tip protection are mandatory, and any tip contact with a patient means immediate discard.
• Date of opening on the bottle. No opened bottle should circulate without it.
• OT discipline. Peri-operative drops (e.g., Moxilux-D in post-cataract care) deserve the strictest handling: opened bottles do not return to general stock, and nothing enters the sterile field that has been stored casually.

The 28-day question, answered accurately

Confusion about "discard 28 days after opening" is common because the 28-day rule belongs to multidose injectables, not eye drops. US regulators and professional bodies (FDA, CMS guidance QSO-22-16-ASC, The Joint Commission, and the American Academy of Ophthalmology) have all clarified that multidose eye drops may be used until the manufacturer's labelled expiry or stated in-use period, provided they are stored as labelled and the tip is never contaminated. Some manufacturers do specify an in-use limit (commonly 28 days or 4 weeks after opening) — in which case the label governs. The correct rule is simple: read the label, write the opening date, follow aseptic technique, and discard on any doubt.

The Patient's Home: Where Most Real-World Use Happens

Patient counselling on storage and hygiene has measurable impact on contamination rates and outcomes:

1. Storage spot. A cool, dry shelf away from sunlight — not the bathroom (humidity), not the car dashboard (extreme heat), not the windowsill.
2. Hand hygiene first. Wash hands before every instillation.
3. Tip discipline. The dropper tip must never touch the eye, lashes, fingers or any surface. A touched tip means a contaminated bottle.
4. Cap back immediately. The cap is the second line of defence; leaving it off invites contamination and evaporation.
5. Don't share. Ever. Not even within the family.
6. Respect the dates. Discard at labelled expiry or the end of the labelled in-use period, whichever comes first. A half-full bottle of Ocufina at month five is not economy — it is risk.
7. Suspensions need shaking. Products formulated as suspensions (many steroid and combination drops, e.g. Brimolux-T class combinations) must be shaken before each use for dose uniformity.

The Indian Climate Problem: Heat, Humidity and Monsoon

Generic storage advice is written for temperate climates; India demands more. The country sits in ICH climatic Zone IVb, which is why domestic stability studies run at 30°C/75% RH — and why real-world logistics must respect the same reality:

• Summer ambient temperatures in unconditioned godowns and transport vehicles routinely exceed 40°C in much of the country. A product labelled "store below 25°C" spending three days on a truck in May is an undocumented excursion, multiplied across the supply chain.
• Monsoon humidity attacks secondary packaging: cartons soften, labels detach, and — critically for stockists — damp cartons can mask or seed fungal contamination of outer packaging. Raised pallet storage, dehumidification and first-in inspection of incoming consignments matter.
• Power reliability makes refrigerated lines fragile; facilities depending on cold rooms need validated backup power and alarmed temperature logging, not just a working compressor.
• Last-mile pharmacy reality: many retail counters lack air-conditioning. Distributors serving them should prioritise products with robust Zone IVb stability files and labelled conditions the retail environment can actually meet.

The practical question to ask any manufacturer: "What do your Zone IVb stability data show, and what labelled storage condition do they justify?" A stability file designed for Indian conditions is a product feature in this market.

Temperature Excursions: A Practical Decision Table

When in doubt, the conservative choice is always replacement: an eye drop is inexpensive; a corneal ulcer is not. And when a suspected product problem is identified, retain the bottle and packaging rather than destroying them — the batch number, physical evidence and remaining contents are exactly what the manufacturer's quality team and the pharmacovigilance system need to investigate properly.

Why This Matters Commercially

For distributors and hospital pharmacies, storage and handling discipline is also a business issue: expired and degraded stock is a direct financial loss, tender committees audit storage conditions, and a single contamination incident traced to ward handling damages institutional reputation. A supplier that supports you with clear labelling, stability summaries, storage guidance and a responsive quality-complaint channel is protecting your margin as well as your patients. Storage discipline is, in the end, the cheapest insurance policy in the entire supply chain — the product has already been paid for; only neglect can still destroy its value.

Frequently Asked Questions

Do eye drops need to be refrigerated in India?

Only if the label says so. Many modern formulations are validated for storage below 25°C or 30°C and travel fine in air-conditioned supply chains; some specific products genuinely require 2–8°C. Never refrigerate or freeze "just in case" — freezing damages many formulations, and condensation invites contamination. Follow the individual product label.

How long can eye drops be used after opening?

Follow the product label. If the manufacturer specifies an in-use period (commonly 28 days or 4 weeks), that governs. If no in-use limit is stated, US regulatory guidance (FDA/CMS, 2022) confirms multidose eye drops may be used until labelled expiry when stored correctly and kept uncontaminated — the 28-day rule belongs to injectables. Write the opening date on every bottle either way.

Can a bottle be shared between patients in a hospital ward?

Best practice is one bottle per patient. Where institutional policy permits multidose bottles across patients, strict aseptic technique is mandatory: no tip contact with any patient or surface, caps replaced immediately, opening dates recorded, and immediate discard on any contamination. Published literature consistently shows tip contamination rises with multi-patient use.

What should I do if eye drops change colour or look cloudy?

Stop using them immediately. A clear solution that has turned cloudy, coloured or particle-containing may indicate degradation, contamination or container failure. Discard the product, record the batch number, and report it to the supplier or pharmacist — this is exactly the kind of signal pharmacovigilance and quality-complaint systems exist to capture.

How can a distributor minimise expiry losses on ophthalmic stock?

Buy against realistic velocity data, insist on high residual shelf life at delivery (60–75% is a fair benchmark), enforce FEFO picking, monitor storage temperatures, flag stock at six months to expiry for rotation or return per the supplier policy, and keep reorder quantities tight on slow-moving chronic lines.

---

This article provides general guidance for industry professionals and patients. Always follow the storage instructions on the specific product label and your ophthalmologist's or pharmacist's advice.

Need storage guidelines, stability summaries or support with a quality complaint? Contact Oculentis Medical — or become a distribution partner with full cold-chain and documentation support.